FDA Corrects Proposed Rule on Biologics Regulations, Eliminates Establishment and Product Licenses

Summary

The Food and Drug Administration (FDA) is correcting a proposed rule that was published with an incorrect address, which proposed to eliminate references to establishment licenses and product licenses for all products regulated under the Public Health Services Act.